top of page
Jenthera
THERAPEUTICS

AT THE FOREFRONT OF
CRISPR THERAPEUTICS DEVELOPMENT
A NOVEL CRISPR TECHNOLOGY
Directly addressing the inherent limitations of current CRISPR methodologies, we seek to unlock previously unattainable avenues in the development of CRISPR based therapeutics.

"WHAT WILL REPLACE Cas9 IS A HIGH FREQUENCY PRECISION EDITING HDR METHODOLOGY"
FIND OUT MORE.
CONTACT US.
AddressesInes
Institut NEOMED
7171 Frederick Banting
Saint-Laurent H4S 1Z9
(Québec) Canada
123 Edward Street, Suite 255
Toronto, M5G 1E2
Canada
bottom of page